ROIVW
Income statement / Annual
Last year (2024), Roivant Sciences Ltd.'s total revenue was $29.05 M,
a decrease of 76.72% from the previous year.
In 2024, Roivant Sciences Ltd.'s net income was -$171.98 M.
See Roivant Sciences Ltd.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
03/31/2025 |
03/31/2024 |
03/31/2023 |
03/31/2022 |
03/31/2021 |
03/31/2020 |
| Operating Revenue |
$29.05 M |
$124.80 M |
$61.28 M |
$55.29 M |
$23.80 M |
$67.69 M |
| Cost of Revenue |
$911.00 K
|
$27.96 M
|
$13.13 M
|
$8.97 M
|
$2.06 M
|
$1.13 M
|
| Gross Profit |
$28.14 M
|
$96.83 M
|
$48.15 M
|
$46.32 M
|
$21.74 M
|
$66.56 M
|
| Gross Profit Ratio |
0.97
|
0.78
|
0.79
|
0.84
|
0.91
|
0.98
|
| Research and Development Expenses |
$550.41 M
|
$501.74 M
|
$525.22 M
|
$483.04 M
|
$236.63 M
|
$263.22 M
|
| General & Administrative Expenses |
$591.41 M
|
$0.00
|
$600.51 M
|
$775.03 M
|
$259.88 M
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$591.41 M
|
$675.04 M
|
$600.51 M
|
$775.03 M
|
$259.88 M
|
$335.77 M
|
| Other Expenses |
-$110.39 M
|
-$5.32 B
|
$97.75 M
|
$139.89 M
|
$596.13 M
|
$0.00
|
| Operating Expenses |
$1.03 B
|
-$4.13 B
|
$1.22 B
|
$1.40 B
|
$1.09 B
|
$598.98 M
|
| Cost And Expenses |
$1.03 B
|
-$4.12 B
|
$1.24 B
|
$1.41 B
|
$1.09 B
|
$600.11 M
|
| Interest Income |
$258.38 M
|
$146.43 M
|
$32.18 M
|
$369.00 K
|
$1.42 M
|
$17.99 M
|
| Interest Expense |
$0.00
|
$34.78 M
|
$27.97 M
|
$7.04 M
|
$2.81 M
|
$7.68 M
|
| Depreciation & Amortization |
$7.33 M
|
$22.04 M
|
$18.86 M
|
$5.93 M
|
$175.16 M
|
-$20.88 M
|
| EBITDA |
-$1.10 B |
$4.31 B |
-$1.18 B |
-$916.71 M |
-$895.74 M |
-$553.30 M |
| EBITDA Ratio |
-37.85
|
34.54
|
-19.22
|
-16.58
|
-37.64
|
-8.17
|
| Operating Income Ratio |
-34.53
|
33.99
|
-19.18
|
-24.45
|
-45.01
|
-7.87
|
| Total Other Income/Expenses Net |
$321.70 M
|
$11.41 M
|
-$49.52 M
|
$427.90 M
|
$172.35 M
|
-$28.56 M
|
| Income Before Tax |
-$681.59 M
|
$4.25 B
|
-$1.22 B
|
-$923.75 M
|
-$898.55 M
|
-$560.99 M
|
| Income Before Tax Ratio |
-23.46
|
34.08
|
-19.99
|
-16.71
|
-37.76
|
-8.29
|
| Income Tax Expense |
$48.17 M
|
$22.22 M
|
$5.19 M
|
$369.00 K
|
$1.69 M
|
$7.12 M
|
| Net Income |
-$171.98 M
|
$4.35 B
|
-$1.01 B
|
-$845.26 M
|
-$809.23 M
|
$1.20 B
|
| Net Income Ratio |
-5.92
|
34.85
|
-16.47
|
-15.29
|
-34.01
|
17.74
|
| EPS |
-0.2371 |
5.55 |
-1.42 |
-1.26 |
-1.18 |
5.21 |
| EPS Diluted |
-0.2371 |
5.23 |
-1.42 |
-1.26 |
-1.18 |
5.21 |
| Weighted Average Shares Out |
$725.40 M
|
$783.25 M
|
$712.79 M
|
$669.75 M
|
$684.79 M
|
$215.35 M
|
| Weighted Average Shares Out Diluted |
$725.40 M
|
$831.05 M
|
$712.79 M
|
$669.75 M
|
$684.79 M
|
$215.35 M
|
| Link |
|
|
|
|
|
|
